Seggern Christopher Von's Insider Trades & SAST Disclosures

Seggern Christopher Von's most recent trade in Xenon Pharmaceuticals Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 11, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Xenon Pharmaceuticals Inc
Seggern Christopher Von Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Mar 2024 100,000 100,000 - - Stock Option (Right to Buy)
Xenon Pharmaceuticals Inc
Seggern Christopher Von Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2023 90,000 90,000 - - Stock Option (Right to Buy)
Xenon Pharmaceuticals Inc
Seggern Christopher Von Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 100,000 100,000 - - Stock Option (Right to Buy)
Xenon Pharmaceuticals Inc
Seggern Christopher Von Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2021 60,000 60,000 - - Stock Option (Right to Buy)
Xenon Pharmaceuticals Inc
Seggern Christopher Von Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2020 100,000 100,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades